Evidence map›Paper›PMID 29084265›Full record

ArticlePLoS pathogens2017

miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence.

Yingpu Yu, Troels K H Scheel, Joseph M Luna, Hachung Chung, Eiko Nishiuchi, Margaret A Scull, Natalia Echeverría, Inna Ricardo-Lax, Amit Kapoor, W Ian Lipkin and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Identification of claudin-3 as an entry factor for rat hepacivirus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Animal Models of Hepatitis C Virus Infection.Cold Spring Harbor perspectives in medicine · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Yingpu YuLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.
Troels K H ScheelLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.
Joseph M LunaLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.ORCID 0000-0003-2415-9203
Hachung ChungLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.
Eiko NishiuchiLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.ORCID 0000-0003-0107-9614
Margaret A ScullLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.
Natalia EcheverríaLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.
Inna Ricardo-LaxLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.ORCID 0000-0002-9590-9692
Amit KapoorDepartment of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
W Ian LipkinCenter for Infection and Immunity, Mailman School of Public Health and College of Physicians & Surgeons, Columbia University, New York, NY, United States of America.
Thomas J DiversDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States of America.
Douglas F AntczakBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States of America.ORCID 0000-0003-3336-5818
Bud C TennantDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States of America.
Charles M RiceLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, United States of America.ORCID 0000-0003-3087-8079
Rockefeller University · USCornell University · USColumbia University · USNationwide Children's Hospital · USUniversidad de la República de Uruguay · UYUniversity of Copenhagen · DK

Funding

A systematic analysis of small RNA interactions during RNA virus infectionsR01AI116943 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2016 to 2020
$3.0M
Host response and liver disease in a hepatitis C-like virus rat modelR01AI137567 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2018 to 2022
$2.5M
NIAID NIH HHS R01 AI116943NIAID NIH HHS R01 AI137567
6 · The paper itself

Abstract

Hepatitis C virus (HCV) requires the liver specific micro-RNA (miRNA), miR-122, to replicate. This was considered unique among RNA viruses until recent discoveries of HCV-related hepaciviruses prompting the question of a more general miR-122 dependence. Among hepaciviruses, the closest known HCV relative is the equine non-primate hepacivirus (NPHV). Here, we used Argonaute cross-linking immunoprecipitation (AGO-CLIP) to confirm AGO binding to the single predicted miR-122 site in the NPHV 5'UTR in vivo. To study miR-122 requirements in the absence of NPHV-permissive cell culture systems, we generated infectious NPHV/HCV chimeric viruses with the 5' end of NPHV replacing orthologous HCV sequences. These chimeras were viable even in cells lacking miR-122, although miR-122 presence enhanced virus production. No other miRNAs bound this region. By random mutagenesis, we isolated HCV variants partially dependent on miR-122 as well as robustly replicating NPHV/HCV variants completely independent of any miRNAs. These miRNA independent variants even replicate and produce infectious particles in non-hepatic cells after exogenous delivery of apolipoprotein E (ApoE). Our findings suggest that miR-122 independent HCV and NPHV variants have arisen and been sampled during evolution, yet miR-122 dependence has prevailed. We propose that hepaciviruses may use this mechanism to guarantee liver tropism and exploit the tolerogenic liver environment to avoid clearance and promote chronicity.

Indexed as

Evolution, MolecularApolipoproteins EArgonaute ProteinsCell Line, TumorEukaryotic Initiation FactorsHepacivirusHepatitis CHumansMicroRNAsMutagenesisViral TropismAGO1 protein, humanApolipoproteins EArgonaute ProteinsEukaryotic Initiation FactorsMicroRNAsMIRN122 microRNA, human

Identifiers

PMID29084265
PMCPMC5679655
OpenAlexW2765111621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.